Display of the human mucinome with defined O-glycans by gene engineered cells
Nason, Rebecca; Büll, Christian; Konstantinidi, Andriana; Sun, Lingbo; Ye, Zilu; Halim, Adnan; Du, Wenjuan; Sørensen, Daniel M; Durbesson, Fabien; Furukawa, Sanae; Mandel, Ulla; Joshi, Hiren J; Dworkin, Leo Alexander; Hansen, Lars; David, Leonor; Iverson, Tina M; Bensing, Barbara A; Sullam, Paul M; Varki, Ajit; Vries, Erik de; de Haan, Cornelis A M; Vincentelli, Renaud; Henrissat, Bernard; Vakhrushev, Sergey Y; Clausen, Henrik; Narimatsu, Yoshiki
(2021) Nature Communications, volume 12, issue 1, pp. 1 - 16
(Article)
Abstract
Mucins are a large family of heavily O-glycosylated proteins that cover all mucosal surfaces and constitute the major macromolecules in most body fluids. Mucins are primarily defined by their variable tandem repeat (TR) domains that are densely decorated with different O-glycan structures in distinct patterns, and these arguably convey much
... read more
of the informational content of mucins. Here, we develop a cell-based platform for the display and production of human TR O-glycodomains (~200 amino acids) with tunable structures and patterns of O-glycans using membrane-bound and secreted reporters expressed in glycoengineered HEK293 cells. Availability of defined mucin TR O-glycodomains advances experimental studies into the versatile role of mucins at the interface with pathogenic microorganisms and the microbiome, and sparks new strategies for molecular dissection of specific roles of adhesins, glycoside hydrolases, glycopeptidases, viruses and other interactions with mucin TRs as highlighted by examples.
show less
Download/Full Text
Keywords: General Chemistry, General Biochemistry,Genetics and Molecular Biology, General Physics and Astronomy
ISSN: 2041-1723
Publisher: Nature Publishing Group
Note: Funding Information: This work was supported by the Lundbeck Foundation, the Novo Nordisk Foundation, the European Commission (GlycoImaging H2020-MSCA-ITN-721297, BioCapture H2020-MSCA-ITN-722171), the Danish National Research Foundation (DNRF107), the Mizutani Foundation (to Y.N.), the European Union’s Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement No 787684 (to C.B.), and the National Institutes of Health grant (R01GM32373 to A.V. and GM137458 to T.M.I.). Publisher Copyright: © 2021, The Author(s).
(Peer reviewed)